<?xml version="1.0" encoding="UTF-8"?>
<p>There are only two RSV antiviral drugs approved by the FDA for the treatment or prevention of serious respiratory tract infections caused by RSV: aerosolized ribavirin for treatment and palivizumab (Synagis
 <sup>Â®</sup>) for prophylaxis.
</p>
